Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall Survival
Statistics in Medicine · 2026-06 · 45 (13-14)
DOI: 10.1002/sim.70574 ↗At a glance
Journal article in Statistics in Medicine, published online on 2026-05-25. Written by Georgios Kazantzidis and 2 co-authors. Institution: F. Hoffmann-La Roche AG, Basel, Switzerland. Major MEDLINE topics: Nonlinear Dynamics, Mediation Analysis, Neoplasms. 38 references. The full text is freely available (open access, CC BY 4.0). Funded by: Roche.
Abstract (original language)
Understanding the mechanisms through which anti‐cancer treatments influence survival is central to improving drug development and evaluation. In this work, we develop a Bayesian joint modeling framework for mediation analysis to quantify the extent to which tumor size dynamics mediate the effect of treatment on overall survival (OS). Our model integrates a nonlinear longitudinal sub‐model describing tumor growth inhibition (TGI) with a parametric survival model, and supports several biologically motivated link functions between tumor size and survival. We explore alternative parameterizations of the treatment effect on tumor shrinkage and regrowth rates and assess their impact on mediation quantities. The approach is implemented using a Bayesian hierarchical joint model. Marginal effects are computed to characterize the proportion of treatment effect (PTE), natural direct effect (NDE), and natural indirect effect (NIE) over time. Through simulations under varying mediation levels and sample sizes, we evaluate bias, coverage, and identifiability of mediation quantities. Application to the IMBrave150 Phase III study suggests that the mediated proportion of the treatment effect varies over time, indicating that tumor dynamics partially but not fully capture the treatment mechanism of action. This framework provides a robust tool to investigate mediation mechanisms in oncology and may contribute to the validation of tumor size as a surrogate endpoint for survival.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- F. Hoffmann-La Roche AG, Basel, Switzerland.
- Bordeaux Population Health Research Center U1219, Inserm, Biostatistics Team, Bordeaux, France.
ORCID profiles: Georgios Kazantzidis
Funding
- Roche
Cite
APA
Kazantzidis, G., Mercier, F., & Rondeau, V. (2026). Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall Survival. Statistics in Medicine, 45(13-14). https://doi.org/10.1002/sim.70574
Vancouver
Kazantzidis G, Mercier F, Rondeau V. Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall Survival. Statistics in Medicine. 2026;45(13-14). doi:10.1002/sim.70574
BibTeX
@article{Kazantzidis2026,
author = {Kazantzidis, Georgios and Mercier, Francois and Rondeau, Virginie},
title = {Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall Survival},
journal = {Statistics in Medicine},
year = {2026},
volume = {45},
number = {13-14},
doi = {10.1002/sim.70574}
}
EUVIMED